Licensee of the Bob Marley name and likeness and manufacturer of natural RTD coffees and Relaxation teas.  Acquired by New Age Beverages in late 2016.

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets.



Prior to founding Kalon Partners, Graham Anderson invested in several companies, helped grow and build them, and helped achieve successful exits for shareholders.  The following are some representative examples of the companies in which Graham has invested:

Prior to founding Kalon Partners, Stu Strumwasser served as investment banker and advisor to the following companies:

In 2013 Pharmaceutical Product Development, LLC (PPD) acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. 

Across hundreds of protocols, Acurian has increased the enrollment productivity of clinical trials without adding sites or time. Acurian provides out-of-practice patients from its opted-in database and other proven recruitment channels. Acurian increases site enrollment performance and helps customers achieve faster trial completion and time-to-market, and achieve peace-of-mind through results-based pricing.

Karma is a manufacturer of branded, premium hydration and probiotics beverages as well as a dispensing cap system for shelf-stabilizing active ingredients.



Kalon Partners is currently looking for great, small, focused, consumer and healthcare companies.   Please contact us for further information.

A Lower Middle Market Private Equity Firm Focused on Consumer and Healthcare Businesses

SkinMedica® is a cosmeceutical company that has been developing innovative skin care treatments that help rejuvenate skin. The company's products have been featured in Elle, INSTYLE, Self, People, Web MD and many other magazines and television shows including The View and The Today Show to name a few.

In 2013, SkinMedica® was acquired by Allergan, itself recently acquired by Actavis.. SkinMedica® scientifically formulated, clinically tested skin care products with TNS® are sold through approved physicians' offices across the country as well as online through